Pascal Touchon
President and Chief Executive Officer
CEO
Board Member
Chairman
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Atara Biotherapeutics, Inc. (ATRA) | D.V.M. Former President and Chief Executive Officer | $503,633 | $1,722,332 |
| 2023 | Atara Biotherapeutics, Inc. (ATRA) | D.V.M. Former President and Chief Executive Officer | $723,450 | $4,375,125 |
| 2022 | Atara Biotherapeutics, Inc. (ATRA) | D.V.M. | $717,938 | $5,158,127 |
| 2021 | Atara Biotherapeutics, Inc. (ATRA) | D.V.M. | $680,625 | $5,117,335 |
| 2020 | Atara Biotherapeutics, Inc. (ATRA) | D.V.M. | $654,857 | $5,285,827 |
| 2019 | Atara Biotherapeutics, Inc. (ATRA) | D.V.M. President & Chief Executive Officer | $319,327 | $6,637,307 |
Executive changes
Earnings-call appearances
-
Atara Biotherapeutics, Inc. Q3 FY2023 Earnings Call2023-11-01
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q3 FY2022 Earnings Call2022-11-08
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q2 FY2022 Earnings Call2022-08-08
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q4 FY2021 Earnings Call2022-01-26
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q3 FY2021 Earnings Call2021-11-04
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q2 FY2021 Earnings Call2021-08-09
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q1 FY2021 Earnings Call2021-05-04
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q4 FY2020 Earnings Call2021-03-01
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q2 FY2020 Earnings Call2020-08-05
Atara Biotherapeutics, Inc. (ATRA)
-
Atara Biotherapeutics, Inc. Q1 FY2020 Earnings Call2020-05-06
Atara Biotherapeutics, Inc. (ATRA)